Evidence map›Paper›PMID 36756111›Full record

ArticleFrontiers in immunology2023

Spatiotemporal local and abscopal cell death and immune responses to histotripsy focused ultrasound tumor ablation.

Ashley L Pepple, Joey L Guy, Reliza McGinnis, Amy E Felsted, Brian Song, Ryan Hubbard, Tejaswi Worlikar, Hannah Garavaglia, Joe Dib, Hannah Chao and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Histotripsy for Liver Tumors: Breakthrough or Hype?Annals of surgical oncology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ashley L PeppleDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Joey L GuyDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Reliza McGinnisDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Amy E FelstedDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Brian SongDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Ryan HubbardDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Tejaswi WorlikarDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Hannah GaravagliaDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Joe DibDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Hannah ChaoDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Nicoleen BoyleDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Michal OlszewskiResearch Service, Ann Arbor VA Healthcare, Ann Arbor, MI, United States.
Zhen XuDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Anutosh GangulyDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Clifford S ChoDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
University of Michigan–Ann Arbor · USVA Ann Arbor Healthcare System · US

Funding

University of Michigan Surgical Oncology Research Training ProgramT32CA009672 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JACQUELINE SARA JERUSS, WEIPING ZOU · 1991 to 2026
$6.0M
Novel, Noninvasive, Rapid Tumor Ablation Technology using HistotripsyR01CA211217 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XU, ZHEN · 2018 to 2022
$2.7M
Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell deathR01CA269394 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI Clifford Cho · 2023 to 2026
$1.8M
Modulation of Pulmonary Defenses in Pathobiology of Chronic InfectionsI01BX000656 · VA · VETERANS HEALTH ADMINISTRATION · PI OLSZEWSKI, MICHAL A · 2011 to 2025
–
Re-engineering the tumor draining lymph node to achieve memory T cell-based adoptive immunotherapyI01BX001619 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI CHO, CLIFFORD · 2014 to 2022
–
BLRD Research Career Scientist Award ApplicationIK6BX005966 · VA · VETERANS HEALTH ADMINISTRATION · PI OLSZEWSKI, MICHAL A · 2022 to 2025
–
BLRD VA I01 BX000656BLRD VA I01 BX001619BLRD VA IK6 BX005966NCI NIH HHS R01 CA211217NCI NIH HHS R01 CA269394NCI NIH HHS T32 CA009672
6 · The paper itself

Abstract

Introduction: Histotripsy is a novel focused ultrasound tumor ablation modality with potent immunostimulatory effects. Methods: To measure the spatiotemporal kinetics of local andabscopal responses to histotripsy, C57BL/6 mice bearing bilateral flank B16 melanoma or Hepa1-6 hepatocellular carcinoma tumors were treated with unilateral sham or partial histotripsy. Treated and contralateral untreated (abscopal) tumors were analyzed using multicolor immunofluorescence, digital spatial profiling, RNA sequencing (RNASeq), and flow cytometry. Results: Unilateral histotripsy triggered abscopal tumor growth inhibition. Within the ablation zone, early high mobility group box protein 1 (HMGB1) release and necroptosis were accompanied by immunogenic cell death transcriptional responses in tumor cells and innate immune activation transcriptional responses in infiltrating myeloid and natural killer (NK) cells. Delayed CD8+ T cell intratumoral infiltration was spatiotemporally aligned with cancer cell features of ferroptosis; this effect was enhanced by CTLA-4 blockade and recapitulated Discussion: We propose that histotripsy may evoke local necroptotic immunogenic cell death, priming systemic adaptive immune responses and abscopal ferroptotic cancer cell death.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAnimalsCell DeathImmunityMiceMice, Inbred C57BLablationferroptosishistotripsyimmunitynecroptosistumorultrasound

Identifiers

PMID36756111
PMCPMC9900174
OpenAlexW4317728404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.